1-2 of 2
Àngela Deyà-Martinez
Close
Sort by
Journal Articles

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Clinical Trials & Observations
Raffaele Badolato, Laia Alsina, Antoine Azar, Yves Bertrand, Audrey A. Bolyard, David Dale, Àngela Deyà-Martínez, Kathryn E. Dickerson, Navid Ezra, Henrik Hasle, Hyoung Jin Kang, Sorena Kiani-Alikhan, Taco W. Kuijpers, Alexander Kulagin, Daman Langguth, Carina Levin, Olaf Neth, Peter Olbrich, Jane Peake, Yulia Rodina, Caroline E. Rutten, Anna Shcherbina, Teresa K. Tarrant, Matthias G. Vossen, Christian A. Wysocki, Andrea Belschner, Gary J. Bridger, Kelly Chen, Susan Dubuc, Yanping Hu, Honghua Jiang, Sunny Li, Rick MacLeod, Murray Stewart, Arthur G. Taveras, Tina Yan, Jean Donadieu
Journal: Blood
Blood (2024) 144 (1): 35–45.
https://doi.org/10.1182/blood.2023022658
Published: 2024
Includes: Supplemental data
Journal Articles

Circulating B-Cell Precursor Cells As Potential Diagnostic and Therapeutic Biomarker in Patients with WHIM Syndrome

Ulrich Salzer, Christoph B. Geier, Maryssa Ellison, Melis Yilmaz, Caroline von Spee-Mayer, Carsten Speckmann, Stephan Ehl, Olaf Neth, Ana Pilar Garcia Garcia, Angela Deya Martinez, Laia Alsina, Katja Sockel, Catharina Schuetz, David E. Potts, Boglarka Ujhazi, Krisztian Csomos, Jolan E. Walter, Klaus Warnatz
Journal: Blood
Blood (2022) 140 (Supplement 1): 2626–2627.
https://doi.org/10.1182/blood-2022-159190
Published: 2022